About Retinoblastoma 

 

 

Retinoblastoma is the most common eye cancer in children below 5 years of age. It occurs in 1 in 15 000 children worldwide. Though it appears rare, it is both sight-threatening and life-threatening. Hereditary forms are bilateral while sporadic are unilateral. For those who are diagnosed with retinoblastoma, survival rates stand at 95% in developed countries compared with 40-50% in developing nations.

Depending upon the mode of presentation, treatment can include enucleation (removal of eyeball), systemic chemotherapy, local chemotherapy, laser, and transpupillary thermotherapy or cryotherapy. 

 
 

Open Eyes Global Inc. (ABN 11 643 529 128) is registered as a Charity with the Australian Charities and Not-For-Profits Commission (ACNC)